STARmed

Founded on innovation and clinical excellence, STARmed America is a global leader in thyroid ablation, pioneering the first thyroid-specific RF equipment since 2002. STARmed received FDA clearance in 2018 and became the first to introduce thyroid RFA to the U.S. Our technology is the most clinically proven, featured in over 80% of global thyroid RFA studies. With over 350,000 patients treated across 100+ countries and a strong U.S. presence in 36 states and 150+ medical facilities, STARmed uniquely provides comprehensive support in clinical, reimbursement, and marketing, ensuring partner success at every step. Our dedication to minimally invasive, patient-centered care drives our global impact.